Search
Search
ASRS: 2024
Diana V. Do, MD
Show Description +
Dr. Do presents outcomes, based on baseline visual acuity, of patients with diabetic macular edema treated with 8 mg aflibercept (Eylea HD, Regeneron) and 2 mg aflibercept (Eylea, Regeneron).
Posted: 8/01/2024
Diana V. Do, MD
Dr. Do presents outcomes, based on baseline visual acuity, of patients with diabetic macular edema treated with 8 mg aflibercept (Eylea HD, Regeneron) and 2 mg aflibercept (Eylea, Regeneron).
Posted: 8/01/2024
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASRS: 2024.
_1722955835.png?auto=compress,format&w=180)
_1722955753.png?auto=compress,format&w=180)
_1722955632.png?auto=compress,format&w=180)
_1722955835.png?auto=compress,format&w=504)
_1722955753.png?auto=compress,format&w=504)
_1722955632.png?auto=compress,format&w=504)
Please log in to leave a comment.